Cargando…
Beta-Blocker Use during Pregnancy Correlates with Less Aortic Root Dilatation in Patients with Marfan's Syndrome
Background Pregnant patients with Marfan's syndrome (MFS) are at an increased risk for adverse aortic outcomes. While beta-blockers are used to slow aortic root dilatation in nonpregnant MFS patients, the benefit of such therapy in pregnant MFS patients remains controversial. The purpose of th...
Autores principales: | Roberts, Emma A., Pistner, Andrew, Osobamiro, Oyinkansola, Banning, Stephanie, Shalhub, Sherene, Albright, Catherine, Horovitz, Ofir, Buber, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers, Inc.
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232026/ https://www.ncbi.nlm.nih.gov/pubmed/37055016 http://dx.doi.org/10.1055/a-2072-0469 |
Ejemplares similares
-
New Screening Tool for Aortic Root Dilation in Children with Marfan Syndrome and Marfan-Like Disorders
por: Wozniak-Mielczarek, Lidia, et al.
Publicado: (2020) -
Does altered aortic flow in marfan syndrome relate to aortic root dilatation?
por: Wang, Hung‐Hsuan, et al.
Publicado: (2016) -
Aortic root dilation in adult patients with Marfan syndrome: Does aortic root stiffness matter?
por: Cox, Kelly, et al.
Publicado: (2022) -
Role of beta-blockers in Marfan's syndrome and bicuspid aortic valve: A time for re-appraisal
por: Vaidyanathan, Balu
Publicado: (2008) -
Marfan's cardiomyopathy is associated with aortic annular and root dilatation in the absence of significant valvular regurgitation
por: Wong, Joyce, et al.
Publicado: (2009)